4/A

PRIMARY DOCUMENT

Company: LIGAND PHARMACEUTICALS INC
Filed: July 3, 2018
Period of Report: June 19, 2018
Accession Number: 0000886163-18-000096

View Document ↗ View on SEC.gov ↗